Visiglide
Payments companies reported to CMS as associated with Visiglide. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Visiglide, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Visiglide
These are the largest totals companies reported as associated with Visiglide. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Muhammad Hasan | Orlando, FL | Gastroenterology (Internal Medicine) | $88,441.49 |
| Simon Lo | Los Angeles, CA | Gastroenterology (Internal Medicine) | $50,858.36 |
| Robert Hawes | Orlando, FL | Gastroenterology (Internal Medicine) | $24,563.44 |
| Venkata Akshintala | Baltimore, MD | Gastroenterology (Internal Medicine) | $18,720.00 |
| Koushik Das | Saint Louis, MO | Gastroenterology (Internal Medicine) | $16,990.88 |
| Dennis Yang | Orlando, FL | Gastroenterology (Internal Medicine) | $12,144.41 |
| Yana Cavanagh | Paterson, NJ | Gastroenterology (Internal Medicine) | $11,455.51 |
| Amy Hosmer | Pittsburgh, PA | Gastroenterology (Internal Medicine) | $10,043.18 |
| David Diehl | Danville, PA | Gastroenterology (Internal Medicine) | $8,525.00 |
| Lionel Dsouza | East Setauket, NY | Gastroenterology (Internal Medicine) | $8,420.30 |
Prescribed Visiglide?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.